VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $38,000 | -94.9% | 2,400 | -93.2% | 0.00% | -100.0% |
| Q4 2017 | $739,000 | +29.4% | 35,500 | +1009.4% | 0.01% | -56.2% |
| Q3 2015 | $571,000 | -89.3% | 3,200 | -88.2% | 0.02% | -90.6% |
| Q1 2015 | $5,337,000 | +2636.9% | 27,018 | +1648.7% | 0.17% | +1445.5% |
| Q2 2014 | $195,000 | -95.4% | 1,545 | -95.2% | 0.01% | -96.2% |
| Q1 2014 | $4,231,000 | +2720.7% | 32,111 | +2133.0% | 0.29% | +1942.9% |
| Q3 2013 | $150,000 | – | 1,438 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |